Medicxi Launches Alys Pharmaceuticals in $100m Seed Funding
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
- Latest
- Trending
Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...
Diversity in biotechnology and venture capital is crucial for driving innovation and breakthroughs in healthcare, according to Dr. Stanley Lewis. ...
Efforts to diversify biotech venture capital funding could lead to innovation, breakthroughs in healthcare, and improved outcomes for minorities.
NHS Gloucestershire partners with Lumi Nova to provide a free app for children with anxiety. Lumi Nova offers quests and ...
Incannex Healthcare makes breakthrough in smoking cessation drug program as FDA approves clinical trials for CannQuit-N chewing gum.
Breakthrough in virtual reality technology controlled by thoughts offers hope for restoring mobility to paralyzed patients. The innovative project also ...
Investing in Biotech ETFs is a compelling way to profit from medical innovation in the fast-paced world of investment opportunities. ...
The use of virtual reality (VR) in biomanufacturing training is addressing the skills gap in the biopharmaceutical and cell and ...
Merrimack Pharmaceuticals is set to dissolve after receiving a $225 million payment for FDA approval. Shareholders will receive a dividend ...
Adicet Bio receives an upgrade from Jones Trading, raising its rating to Buy with a new price target of $6.00. ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.